Quarterly report [Sections 13 or 15(d)]

Consolidated Condensed Statements of Stockholders' Equity

v3.25.3
Consolidated Condensed Statements of Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock and Capital in Excess of Par Value
Common Stock and Capital in Excess of Par Value
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period of Adoption, Adjusted Balance
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
Noncontrolling Interest
Noncontrolling Interest
Cumulative Effect, Period of Adoption, Adjusted Balance
Common stock, shares outstanding, beginning (in shares) at Dec. 30, 2023     4,228              
Total stockholders' equity, beginning at Dec. 30, 2023 $ 109,965   $ 36,649   $ (215)   $ 69,156   $ 4,375  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) (19,080)           (18,630)   (450)  
Other comprehensive income (loss) 30       30          
Net proceeds from sales of subsidiary shares and partner contributions 12,278   $ 11,012           1,266  
Employee equity incentive plans and other (in shares)     96              
Employee equity incentive plans and other 986   $ 986              
Share-based compensation 2,759   $ 2,618           141  
Restricted stock unit withholdings (in shares)     (15)              
Restricted stock unit withholdings (475)   $ (600)       125      
Cash dividends declared (1,599)           (1,599)      
Common stock, shares outstanding, ending (in shares) at Sep. 28, 2024     4,309              
Total stockholders' equity, ending at Sep. 28, 2024 104,864   $ 50,665   (185)   49,052   5,332  
Common stock, shares outstanding, beginning (in shares) at Jun. 29, 2024     4,276              
Total stockholders' equity, beginning at Jun. 29, 2024 120,434   $ 49,763   (696)   66,162   5,205  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) (16,989)           (16,639)   (350)  
Other comprehensive income (loss) 511       511          
Net proceeds from sales of subsidiary shares and partner contributions 417   $ 0           417  
Employee equity incentive plans and other (in shares)     38              
Employee equity incentive plans and other 355   $ 355              
Share-based compensation 800   $ 740           60  
Restricted stock unit withholdings (in shares)     (5)              
Restricted stock unit withholdings (128)   $ (193)       65      
Cash dividends declared (536)           (536)      
Common stock, shares outstanding, ending (in shares) at Sep. 28, 2024     4,309              
Total stockholders' equity, ending at Sep. 28, 2024 $ 104,864   $ 50,665   (185)   49,052   5,332  
Common stock, shares outstanding, beginning (in shares) at Dec. 28, 2024 4,330     4,330            
Total stockholders' equity, beginning at Dec. 28, 2024 $ 105,032 $ 105,081   $ 50,949   $ (711)   $ 49,081 [1]   $ 5,762
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) 359           324   35  
Other comprehensive income (loss) 730       730          
Net proceeds from stock issuances and warrants (in shares) [2]       362            
Net proceeds from stock issuances and warrants [2] 3,758     $ 3,758            
Net proceeds from sales of subsidiary shares and partner contributions 4,574   $ 58           4,516  
Partner distributions (159)               (159)  
Employee equity incentive plans and other (in shares)     88              
Employee equity incentive plans and other 777   $ 777              
Share-based compensation 1,896   $ 1,696           200  
Restricted stock unit withholdings (in shares)     (14)              
Restricted stock unit withholdings $ (286)   $ (483)       197      
Common stock, shares outstanding, ending (in shares) at Sep. 27, 2025 4,766   4,766              
Total stockholders' equity, ending at Sep. 27, 2025 $ 116,730   $ 56,755   19   49,602   10,354  
Common stock, shares outstanding, beginning (in shares) at Jun. 28, 2025       4,377            
Total stockholders' equity, beginning at Jun. 28, 2025   $ 105,751   $ 52,334   $ 65   $ 45,484   $ 7,868
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) 4,270           4,063   207  
Other comprehensive income (loss) (46)       (46)          
Net proceeds from stock issuances and warrants (in shares) [2]       362            
Net proceeds from stock issuances and warrants [2] 3,758     $ 3,758            
Net proceeds from sales of subsidiary shares and partner contributions 2,336   $ 60           2,276  
Partner distributions (68)               (68)  
Employee equity incentive plans and other (in shares)     32              
Employee equity incentive plans and other 286   $ 286              
Share-based compensation 548   $ 477           71  
Restricted stock unit withholdings (in shares)     (5)              
Restricted stock unit withholdings $ (105)   $ (160)       55      
Common stock, shares outstanding, ending (in shares) at Sep. 27, 2025 4,766   4,766              
Total stockholders' equity, ending at Sep. 27, 2025 $ 116,730   $ 56,755   $ 19   $ 49,602   $ 10,354  
[1] The retained earnings balance as of December 28, 2024 includes an opening balance adjustment made as a result of the adoption of a new accounting standard in 2025.
[2] Includes $110 million of allocated proceeds to warrants from the Warrant and Common Stock Agreement with the U.S. government.
See accompanying notes.